Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04728594 · ClinicalTrials.gov registry record · NA
Emails Promoting COVID-19 Vaccination Among Healthcare Workers
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 9,566
- Enrollment target
NCT04728594 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 9,566 participants.
The verdict
NCT04728594, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 9,566 participants
- Enrollment target
Study Summary
In this evaluation, two versions of emails will be sent to Geisinger employees who have not been vaccinated against COVID-19. A delayed-contact control group will be emailed after a delay of at least two days. The researchers hypothesize that either of the emails - which use content informed by behavioral nudge theory - will lead to more COVID-19 vaccinations than the delayed-contact control group.
Interventions
- BEHAVIORAL Social Proof
- BEHAVIORAL Reframing
- BEHAVIORAL Scarcity Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,566 participants |
| Start Date | 2021-01-15 |
| Est. Completion | 2021-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04728594
The ClinicalTrials.gov registry entry for NCT04728594 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9,566 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Social Proof is the first listed.
NCT04728594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04728594 about?
NCT04728594 is a clinical study titled "Emails Promoting COVID-19 Vaccination Among Healthcare Workers". In this evaluation, two versions of emails will be sent to Geisinger employees who have not been vaccinated against COVID-19. A delayed-contact control group will be emailed after a delay of at least two days. The researchers hypothesize that either of the emails - which use content informed by beha...
What is the current status of trial NCT04728594?
This trial is currently completed. It is a NA study. The enrollment target is 9,566 participants. The study started on 2021-01-15. Estimated completion is 2021-01-20.
What interventions are being tested in trial NCT04728594?
The interventions under investigation include: Social Proof (BEHAVIORAL), Reframing (BEHAVIORAL), Scarcity Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT04728594?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.